Updated: February 2, 2012 < Return to Open Clinical Trials >
Below are the current open Clinical Trials at BCCA - Fraser Valley Centre (FVC):
If you are interested in more information about a particular trial, please talk with your treating physician first, and they may contact this centre for further information if necessary.
| Tumour Group / Site |
Trial Title |
Opening Date |
| Breast |
A Phase III Randomized Trial of Metformin Versus Placebo on Recurrence and Survival in Early Stage Breast Cancer (MA 32) |
Sept 2010 |
| GI |
A Randomized Phase III Study of 5-FU Based Regimen with or without Oxaliplatin as Second Line Treatment of Advanced or Metastatic Pancreatic Cancer in Patients who have Previously Received Gemcitabine Based Chemotherapy (Pancreox) |
Mar 2011 |
| GI |
An Open-label, Multicenter, Randomized Phase 2 Study Evaluating the Safety and Efficacy of 5-FU/FA and Oxaliplatin (Modified FOLFOX-6) in Combination with IMC-1121B or IMC-18F1 or Without Investigational Therapy as Second-Line Therapy in Patients with Metastatic Colorectal Cancer Following Disease Progression on First-Line Irinotecan-based Therapy (ImClone) |
November 2010 |
| GI |
A Phase III Trial of 6 Versus 12 Treatments of Adjuvant Folfox Plus Celecoxib or Placebo for Patients with Resected Stage III Colon Cancer (CRC6) |
November 2011 |
| GU |
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Theray (Ascende-RT) |
|
| GU |
RADICALS: Radiotherapy and Androgen Deprivation in Combination After Local Surgery. A Randomized Controlled Trial in Prostate Cancer. ( PR 13) |
December 2010 |
| GU |
A Randomized Phase III Study Comparing Standard First Line DOCEtaxel/Prednisone to DOCEtaxel/Prednisone in Combination with Custirsen (OGX-011) in Men with Metastatic Castrate Resistant Prostate Cancer (OGX-011) |
Mar 2011 |
| GYNE |
A Phase II-III Study of Intraperitoneal (IP) Plus Intravenous(IV) Chemotherapy versus IV Carboplatin Plus Paclitaxel in Patients with Epithelial Ovarian Cancer Optimally Debulked at Surgery Following Neoadjuvant Intravenous Chemotherapy(OV 21) |
November 2011 |
| Lung |
A Double Blind Placebo Controlled Randomized Trial of PF-804 in Patients with Incurable Stage IIIB/IV Non-Small Cell Lung Cancer after Failure of Standard Therapy for Advanced or Metastatic Disease (BR 26) |
March 2010 |
| Lung |
A Phase III, Randomized, Double-Blinded, Placebo-Controlled Study of ARQ 197 plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Subjects with Locally Advanced or Metastatic, Non-Squamous, Non-Small Cell Lung Cancer (NSCLC) (ARQ) |
Jan 2012 |
| Lymphoma |
Phase II Trial Investigating Tailoring First-Line Therapy for Advance Stage Diffuse Large B-Cell Non-Hodgkin's Lymphoma based on Mid-Treatment Positron Emmission Tomography (PET) Scan Results. (LYTPET) |
August 2006 |
| Melanoma |
A Randomized Phase II Study of Interleukin-21 (rlL-21) versus Dacarbazine (DTIC) in Patients with Metastatic or Recurrent Melanoma (IND 202) |
June 2011 |
| Pain & Symptom |
A Phase III Double-Blind Study of Dexamethasone versus Placebo in the Prophylaxis of Radiation-Induced Pain Flare Following Palliative Radiotherapy for Bone Metastases (SC 23) |
November 2011 |